Anti-Cytomegalovirus antibody (FITC) (ab155843)
- Datasheet
- References
- Protocols
Overview
-
Product nameAnti-Cytomegalovirus antibody (FITC)
See all Cytomegalovirus primary antibodies -
DescriptionGoat polyclonal to Cytomegalovirus (FITC)
-
Host speciesGoat
-
ConjugationFITC. Ex: 493nm, Em: 528nm
-
Tested applicationsSuitable for: WB, ICC/IFmore details
-
Species reactivityReacts with: Other species
-
Immunogen
Purified virions of strain AD169.
-
General notesImmunoglobulin concentration is 4-5 mg/ml. Unit size is 1.0 ml.
Properties
-
FormLiquid
-
Storage instructionsShipped at 4°C. Store at +4°C.
-
Storage bufferpH: 7.20
Preservative: 0.1% Sodium azide
Constituents: 98% PBS, 1% BSA -
Concentration information loading... -
Purification notesab155843 consists of purified IgG fraction of the antiserum covalently coupled with high purity Isomer I of fluorescein isothiocyanate. Care is taken to ensure complete removal of any free fluorescein from the final product.
-
ClonalityPolyclonal
-
IsotypeIgG
-
Research areas
Associated products
-
Compatible Secondaries
-
Isotype control
Applications
Our Abpromise guarantee covers the use of ab155843 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| WB | Use at an assay dependent concentration. | |
| ICC/IF | 1/10 - 1/50. Acetone fixation of the antigen source is recommended prior to staining. |
Target
-
RelevanceCytomegalovirus is a member of the herpes virus group, which includes herpes simplex virus types 1 and 2, varicella zoster virus (which causes chicken pox), and Epstein Barr virus (which causes infectious mononucleosis). These viruses share a characteristic ability to remain dormant within the body over a long period.
-
Alternative names
- 65 kDa phosphoprotein antibody
- Envelope glycoprotein B antibody
- Human herpesvirus 5 antibody
see all
References
ab155843 has not yet been referenced specifically in any publications.
